Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calendar
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calendar
    • Contact
  • Next Generation Dx Summit
 
  • Laser Microscope Hits The Trifecta With Diagnostic, Treatment, Research Potential

    Diagnostics World News | Laboratory groups the world over have applied a multiphoton laser microscope directly to the skin to peer at living tissue using a beam of light. But University of British Columbia researchers are the first to demonstrate that the same instrument can also treat tissue simply by turning up the power of the laser.

    Jun 11, 2019
  • Liquid Biopsy And Art In Science: Future Directions

    Diagnostics World News | Milana Frenkel-Morgenstern, head of the Cancer Genomics and Biocomputing of Complex Diseases Lab at Bar-Ilan University, explores how her work is informed by both bioinformatics and cancer genomics, the link between art and science, and more.

    Jun 5, 2019
  • Roche, GE Healthcare Launch NAVIFY Tumor Board 2.0

    Diagnostics World News Brief | Roche announced the release of NAVIFY Tumor Board 2.0, the first collaboration product from their partnership with GE Healthcare.

    Jun 3, 2019
  • Liquid Biopsy And Its Evolving Role In Precision Medicine

    Diagnostics World News | Liquid biopsy markers have played an integral role in precision medicine. However, there are a number of challenges with the expansion of liquid biopsy markers into the drug discovery and drug testing field, mostly due to the rather evolutionary nature.

    Jun 3, 2019
  • Baltimore Firm Raises $110 Million To Bring Johns Hopkins' Cancer-Detecting Blood Test To Market

    The Baltimore Sun | A newly formed Baltimore company has raised $110 million to commercialize a cancer-detecting blood test, developed by Johns Hopkins researchers, that doctors would give patients during routine physicals.

    May 31, 2019
  • Forming A New Diagnostics Landscape: An Overview Of The Next Generation Dx Summit

    Diagnostics World News | At the Next Generation Dx Summit, a full program will explore point-of-care diagnostics, immuno-oncology, digital pathology and AI, and all of the accompanying regulatory and reimbursement questions.

    May 31, 2019
  • Washington University, University of North Carolina Team To Evaluate Infant Autism Diagnosis

    Diagnostics World News Brief | A multicenter research team led jointly by Washington University School of Medicine in St. Louis and the University of North Carolina at Chapel Hill has received a five-year, $9.5 million grant to further evaluate whether brain imaging can help detect very high risk of autism spectrum disorder in early infancy. Researchers believe that if they can detect evidence of the disorder earlier, behavioral interventions can begin sooner than currently possible, which may help improve outcomes for affected children.

    May 30, 2019
  • Two Pore Guys Is Rebranding, TTP, And More: News From May 2019

    Diagnostics World News | May featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Two Pore Guys, TTP, Caris, and more.

    May 30, 2019
  • The Challenges Of Conducting Precision Oncology Trials On A Global Scale

    Diagnostics World News | Conducting a trial in various countries requires quite a learning curve, from varying regulatory requirements to the simple language barrier.

    May 29, 2019
  • The Reliability Of Bioassay And Their Impact On The Consumer

    Diagnostics World News | With the reliability of bioassays being a concern, change is inevitable. A certain level of re-education is required, both for the primary care doctors and the patients themselves.

    May 28, 2019
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy